Cloud Banner

Healthcare

Image

Global Drug Screening Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 150 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Drug Screening Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 17.299999999999997% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 6.22 Billion
Diagram Market Size (Forecast Year) USD 22.28 Billion
Diagram CAGR 17.299999999999997%

Global Drug Screening Market, By Product and Services (Equipment, Rapid Testing Devices (RTD), Consumables and Laboratory Services), Sample Type (Oral Fluid or Saliva, Breath, Hair, Urine, Other Samples), End User (Workplace and Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers) - Industry Trends and Forecast to 2030.

Drug Screening Market Analysis and Size

The surging usage of drugs across the globe has accelerated drug screening adoption. According to the World Drug Report 2021, drug use disorders were estimated to affect 36.3 million people worldwide in 2019, accounting for nearly 13% of the global population. Drug use killed nearly half a million people in the same year, and drug use disorders resulted in the loss of 18 million years of healthy life, primarily due to opioids. The stringent regulations are imposed widely for subsiding the consumption of the drug.

Data Bridge Market Research analyses that the drug screening market, which was USD 6.22 billion in 2022, would reach up to USD 22.28 billion by 2030 and is expected to undergo a CAGR of 17.30% during the forecast period. The “urine” dominates in the sample type segment of the drug screening market owing to its benefits, such as cost-effectiveness, high detection accuracy of multiple drugs, and instant results. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Drug Screening Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product and Services (Equipment, Rapid Testing Devices (RTD), Consumables and Laboratory Services), Sample Type (Oral Fluid or Saliva, Breath, Hair, Urine, Other Samples), End User (Workplace and Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina, and Rest of South America as part of South America.

Market Players Covered

LabCorp (U.S.), Quest Diagnostics (U.S.), Abbott (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Alfa Scientific Designs, Inc. (U.S.),  OraSure Technologies, Inc. (U.S.), Siemens (Germany),  F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (U.S.), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (U.S.), Omega Laboratories, Inc. (U.S.), Psychemedics Corporation (U.S.), Clinical Reference Laboratory Inc., (U.S.), American Bio Medica Corporation (U.S.), ACM Global Laboratories (U.S.), Sciteck, Inc. (U.S.), Synens SAS (France), Intoximeters (U.S.), AccuSource Inc., (U.S.), Cordant Health Solutions (U.S.), and Millennium Health (U.S.)

Market Opportunities

  • Technological advancements
  • Preventative healthcare initiatives by the market players

Market Definition

Drug screening helps to identify the existence of drugs or their metabolic by-products in an individual's biological specimen, frequently urine, blood, saliva, or hair. Employers, healthcare providers, and law enforcement entities commonly deploy drug screening to evaluate drug usage or misuse. This pre-emptive measure aids in upholding workplace security, adhering to regulations, and pinpointing potential health hazards. The screening process typically involves laboratory examination or swift tests and aims to recognize the presence of elements such as cannabis, cocaine, opioids, amphetamines, and other regulated drugs.

Global Drug Screening Market Dynamics

Drivers

  • Rising Workplace Regulations for Employees

Stringent employment regulations and workplace policies necessitate routine drug testing, particularly in safety-sensitive industries such as transportation, construction, and healthcare. Employers must implement drug screening programs to adhere to legal requirements, ensuring a safe working environment and minimizing potential liabilities. This driver underscores the critical role of drug testing in maintaining workplace safety, employee well-being, and compliance with industry-specific standards.

  • Rising Substance Abuse Issues

The escalating prevalence of substance abuse problems, including the opioid crisis, propels the demand for robust drug screening measures. Industries and healthcare organizations face the challenge of promptly identifying and addressing substance abuse to mitigate its impact on individual health and overall societal well-being. The urgent need to combat substance abuse-related issues positions drug screening as a crucial tool in early detection, intervention, and prevention, aligning with broader public health objectives and regulatory imperatives.

Opportunities

  • Technological Advancements

The growth in the drug screening market is likely to spur significant technological advancements in testing methodologies. Innovations may include the development of more sensitive and specific testing kits, quicker and non-invasive screening methods, and incorporating cutting-edge technologies, such as nanotechnology or biosensors. These advancements enhance the accuracy and efficiency of drug screening and contribute to a broader range of substances that can be detected. Additionally, improved technology may lead to more user-friendly testing processes, making drug screening more accessible across various industries and applications.

  • Preventive Healthcare Initiatives

The expansion of drug screening could foster a shift towards preventive healthcare initiatives. Regular and widespread screening for substance abuse may become a proactive approach to identify and address potential health issues associated with drug use. This shift aligns with a broader trend in healthcare towards prevention rather than just treatment. Early detection of substance abuse through screening can enable healthcare providers to intervene promptly, offering counseling, support, or rehabilitation services. This benefits individuals by addressing health concerns early on and contributes to the overall well-being of communities by reducing the societal impact of substance abuse.

Restraints/Challenges

  • False Positives and Negatives

The challenge of false positives and negatives in drug screening arises from the inherent complexities of human metabolism and the potential for cross-reactivity with certain medications. False positives can occur when a test incorrectly indicates the presence of a substance, potentially causing unwarranted consequences for the individual. Conversely, false negatives may occur when a test fails to detect actual drug use. Addressing these challenges involves continual refinement of testing methods, considering individual variations, and educating stakeholders about factors influencing test accuracy.

  • Evolving Drug Trends

Introducing new and synthetic substances is expected to challenge traditional drug screening methods. As the chemical composition of drugs changes, tests must adapt to identify emerging substances accurately. This requires ongoing research and development in testing technologies to ensure that screening protocols remain effective and up-to-date. The challenge extends to the need for regulatory bodies and testing organizations to respond proactively to shifts in drug consumption patterns, guiding the detection of novel substances.

This drug screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In August 2021, Select Health of South Carolina and Quest Diagnostics reached an agreement to expand Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees and improve members' access to diagnostics information services
  • In May 2020, Psychemedics Corporation introduced a Vaping Panel to detect the use of Marijuana, CBD, and Nicotine. This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods, including electronic cigarettes or smoking

Global Drug Screening Market Scope

The global drug screening market is segmented on the basis of product and services, sample type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

  • Equipment
  • Rapid Testing Devices (RTD)
  • Consumables
  • Laboratory Services

Sample Type

  • Oral Fluid or Saliva
  • Breath
  • Hair
  • Urine
  • Other Samples

End User

  • Workplace and Schools
  • Criminal Justice Systems and Law Enforcement Agencies
  • Drug Testing Laboratories
  • Drug Treatment Centers
  • Hospitals
  • Personal Users
  • Pain Management Centers

Global Drug Screening Market Regional Analysis/Insights

The drug screening market is analyzed, and market size insights and trends are provided by country, product and services, sample type, and end user, as referenced above.

The countries covered in the global drug screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and rest of South America as part of South America.

North America dominates the drug screening market because of the increasing ingesting of illegal drugs, accessibility of government backing to control drug abuse, and rules encouraging drug screening within the region.

Asia-Pacific is expected to witness significant growth during the forecast period due to increasing awareness of the importance of workplace safety and employee well-being in the Asia-Pacific region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The drug screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug screening market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Drug Screening Market Share Analysis

The drug screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the global drug screening market are:

  • LabCorp (U.S.)
  • Quest Diagnostics (U.S.)
  • Abbott (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Alfa Scientific Designs, Inc. (U.S.)
  • OraSure Technologies, Inc. (U.S.)
  • Siemens (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • MPD Inc. (U.S.)
  • Shimadzu Corporation (Japan)
  • Lifeloc Technologies, Inc. (U.S.)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Premier Biotech, Inc. (U.S.)
  • Omega Laboratories, Inc. (U.S.)
  • Psychemedics Corporation (U.S.)
  • Clinical Reference Laboratory Inc. (U.S.)
  • American Bio Medica Corporation (U.S.)
  • ACM Global Laboratories (U.S.)
  • Sciteck, Inc. (U.S.)
  • Synens SAS (France)
  • Intoximeters (U.S.)
  • AccuSource Inc., (U.S.)
  • Cordant Health Solutions (U.S.)
  • Millennium Health (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The drug screening market will be worth USD 22.28 billion by 2030.
The drug screening market growth rate is 17.30% during the forecast period.
Stringent employment regulations and workplace policies necessitate routine drug testing & escalating prevalence of substance abuse problems are the growth drivers of the drug screening market.
The product and services, sample type, and end user are the factors on which the drug screening market research is based.
Select Health of South Carolina and Quest Diagnostics reached an agreement to expand Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees and improve members' access to diagnostics information services & Psychemedics Corporation introduced a Vaping Panel to detect the use of Marijuana, CBD, and Nicotine are the latest developments in the drug screening market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials